Jesenak M.,University Hospital in Martin
Advances in Respiratory Therapy Research | Year: 2014
The Book represents an actual view on the current trends in the area of respiratory therapy research. The amount of new information in each field of clinical medicine is astonishing and therefore we considered it very important to catch this exciting movement in the form of monograph dedicated to the advances in therapy research of various respiratory diseases. The chapters analyze the therapeutic strategies and perspectives in the management of the most common chronic diseases, especially in childhood. Due to very rapid progress in this area, it is very important that the authors succeed in summarizing the most knowledge and data about the available and possible future therapies of bronchial asthma, primary ciliary dyskinesia, chronic and acute cough, and obstructive sleep apnea syndrome. Aside from clinical chapters, the readers can also find experimental studies analyzing the possible therapeutic application of different medications and chest physiotherapy. A very important part of each chapter is the current view on the pathogenesis of particular diseases, in which understanding is crucial for better, targeted therapy and research of novel therapeutic modalities. We hope that this book will find its readers and will help physicians and other interested people to understand the most recent trends in the treatment and management of respiratory diseases. © 2015 by Nova Science Publishers, Inc. All rights reserved. Source
Sarlinova M.,Comenius University |
Majerova L.,Comenius University |
Matakova T.,Comenius University |
Musak L.,Comenius University |
And 4 more authors.
Advances in Experimental Medicine and Biology | Year: 2014
Chromium is a well known carcinogen involved in the lung cancer development. Polymorphism of some of the DNA repair genes may be associated with elevated risk of cancerous transformation. In the present study, we investigated the polymorphisms of the following selected members of the base and nucleotide excision repair genes: XPC (Lys939Gln), XPD (Lys751Gln), XRCC1(Arg399Gln), and hOGG1 (Ser326Ser), and the risk they present toward the development of lung cancer, with emphasis on the effect of chromium exposure. We analyzed 119 individuals; 50 patients exposed to chromium with diagnosed lung cancer and 69 healthy controls. Genotypes were determined by a PCR-RFLP method. We found a significantly increased risk of lung cancer development in XPD genotype Lys/Gln (OR ¼ 1.94; 95 % CI ¼ 1.10–3.43; p ¼ 0.015) and in the gene combinations: XPD Lys/Gln+XPC Lys/Gln (OR ¼ 6.5; 95 % CI ¼ 1.53–27.49; p ¼ 0.009) and XPD Lys/Gln+XPC Gln/Gln(OR ¼ 5.2; 95 % CI ¼ 1.07–25.32; p ¼ 0.04). In conclusion, gene polymorphisms in the DNA repair genes may underscore the risk of lung cancer development in the chromiumexposed individuals. © Springer International Publishing Switzerland 2014. Source
Dedinska I.,University Hospital in Martin |
Dedinska I.,Comenius University |
Laca L.,University Hospital in Martin |
Laca L.,Comenius University |
And 10 more authors.
Diabetologia Kliniczna | Year: 2014
Background. We define metabolic syndrome as a non-random collective incidence of glucose metabolism disorders related to insulin resistance, central obesity, dyslipidemia, arterial hypertension and other factors which contribute to increased risk of ischemic heart disease and diabetes mellitus type 2. Smoking is one of the most significant risk factors for ischemic heart disease. Objectives and methods. A prospective analysis of 125 patients (75 men and 50 women) with the average age of 57.3 years. A subset of smokers was composed of 59 patients; the average number of cigarettes smoked per day was 18 pieces. A subset of non-smokers was composed of 66 patients. We examined the presence of metabolic syndrome components according to the International Diabetic Federation criteria for the European population throughout the whole set of patients. Results. Percentually higher incidence of metabolic syndrome occurred in the group of non-smokers. The incidence of metabolic syndrome in the group of smokers was significantly influenced by their age. Arterial hypertension and impaired fasting glucose were the most frequent components of metabolic syndrome in the subset of smokers with metabolic syndrome. In the subset of non-smokers with metabolic syndrome arterial hypertension was the most frequently found component. Conclusion. The results of the research did not show statistically significantly increased or decreased incidence of metabolic syndrome in case of smokers. We did not find any relation between the number of cigarettes smoked per day and metabolic syndrome development. Copyright © 2014 Via Medica. Source
Dzian A.,University Hospital in Martin |
Halasova E.,University Hospital in Martin |
Matakova T.,University Hospital in Martin |
Kavcova E.,University Hospital in Martin |
And 4 more authors.
Neoplasma | Year: 2012
Slovak Republic belongs to the countries with high incidence of lung cancer. Gene polymorphisms of the glutathione S-transferases (GSTs) may play a role in individual lung cancer susceptibility. In presented case-control study we investigate the incidence of polymorphism of GSTT1, GSTM1, GSTP1 genes and their combinations as possible predictive factors for identification of individuals with increased risk of formation and development of adenocarcinoma (AC) and squamous cell carcinoma (SCC) of lung in Slovak population. The study was conducted on 520 individuals consisting of 118 patients with adenocarcinoma, 112 patients with squamous cell carcinoma and 290 control individuals. GSTT1, GSTM1, GSTP1 gene polymorphisms were assayed by standard PCR and PCR-RFLP technique. The results of this study indicate that the GSTT1null-genotype and combination GSTT1 null and Ile/Val or Val/Val are associated with increased risk of lung adenocarcinoma. A significant association with 2.13 - fold increased risk was observed between lung adenocarcinoma and GSTT1 null genotype (95% CI = 1.29 - 3.51; p= 0.004). Also it was proved 2.83 times statistically higher risk for development of this histological type of lung cancer (95% CI = 1.34 - 6.01; P = 0.005) in combination of GSTT1null and Ile/Val or Val/Val genotypes. GSTT1, GSTM1, GSTP1 polymorphism did not show any significant association with SCC. Our study suggests that genetic make-up in metabolizing genes may increase susceptibility towards lung cancer development. Source